Actively Recruiting
Preoperative Endoscopic Pancreatic Stent for Distal Pancreatectomy
Led by Chinese University of Hong Kong · Updated on 2022-03-28
56
Participants Needed
1
Research Sites
217 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Distal pancreatectomy (DP) with or without splenectomy is commonly indicated for pancreatic body or tail lesions. Postoperative pancreatic fistula (POPF) remains the commonest complication after DP. A pre-operatively placed pancreatic stent across papilla can decrease the pressure gradient between pancreatic duct and duodenum. Therefore, the pancreatic juice flow is redirected from the pancreatic transection plane and leakage from pancreatic stump is much reduced. This study aims to evaluate whether pre-operatively placed pancreatic stent can prevent POPF by a randomized controlled trial.
CONDITIONS
Official Title
Preoperative Endoscopic Pancreatic Stent for Distal Pancreatectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age >18 years
- Elective distal pancreatectomy for primary pancreatic pathology
You will not qualify if you...
- Informed consent not available
- Emergency distal pancreatectomy
- Presence of pancreatic duct stricture
- Presence of altered anatomy that precludes safe Endoscopic Retrograde Cholangiography (e.g. previous Billroth II gastrectomy)
- History of severe pancreatitis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Prince of Wales Hospital
Hong Kong, Hong Kong
Actively Recruiting
Research Team
K
Kit Fai Lee, MBBS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here